LENZ Therapeutics Reports Q1 2026 Performance, Targets 15,000 HCPs
LENZ Therapeutics delivered Q1 2026 results consistent with expectations, achieving $1.9 million in net revenue and approximately 25,000 prescriptions. The company also...

LENZ Therapeutics delivered Q1 2026 results consistent with expectations, achieving $1.9 million in net revenue and approximately 25,000 prescriptions. The company also...

Crude oil and gasoline prices surged on Monday following President Trump's rejection of Iran's latest peace proposal, prolonging the closure of the...

Almonty Industries announced a significant turnaround in Q1 2026, with revenue soaring 221% to $25.4 million, driven by record tungsten prices and...

Cronos Group Inc. (CRON) targets a summer 2026 close for its CanAdelaar transaction and renews a $50 million share buyback, following record...

Soybean futures climbed Monday, supported by accelerated domestic planting and strong weekly export volumes. Market participants now look to the upcoming USDA...

Saudi Aramco CEO Amin Nasser warns global oil markets may not normalize until 2027, citing Strait of Hormuz disruptions unless the Iran...

As the SEC considers ending quarterly earnings, one perspective argues for real-time reporting, leveraging AI to enhance transparency and mitigate short-term market...

Investors face a busy Monday as Barrick Mining, Constellation Energy, and dozens of other firms release earnings reports before the market opens....

Elevra Lithium has agreed to sell its interest in the Ewoyaa Lithium Project in Ghana to Huayou for US$71 million, aiming to...